Loading…
Portfolio as on Aug 2026 · 11 equity positions
quant Healthcare Fund is a Smart-Beta / Factor scheme managed by Quant MF Mutual Fund. As of disclosures dated Aug 2026, the scheme holds 11 equity positions with an estimated equity AUM of ₹363.92 Cr. The portfolio is anchored by its top conviction bet on Glaxosmithkline Pharmaceuticals, which commands a weight of 10.58%of the fund's total assets.
From a sector allocation perspective, the fund managers have concentrated their largest bet on Pharmaceuticals & Biotechnology, representing 91.54% of the equity portfolio. This is followed by Food Products (8.03%) and Fertilizers & Agrochemicals (0.44%). Under SEBI's guidelines and based on its underlying assets, this scheme carries a Very High Risk risk classification.
₹18.92 per unit +19.4% vs Oct '25
Last 365 days · daily NAV from AMFI · quant Healthcare Fund
Based on ~12 months of weekly NAV history from AMFI. Volatility is the annualized standard deviation of NAV returns. Sharpe ratio and alpha assume a 6.5% risk-free rate. Beta measures how much the fund moves with its benchmark (1.0 = in step); alpha is the return above what that beta would predict. Measured against the NAV of Kotak Nifty 50 Index Fund, standing in for the NIFTY 50 itself. A tracker's NAV is the index minus its running costs, so this compares funds against an investable benchmark rather than a costless one. Past performance does not guarantee future returns — not investment advice.
Top 10 holdings make up 70.0% of the portfolio · top 5 = 43.8%.
| # | ||||
|---|---|---|---|---|
| 1 | Glaxosmithkline PharmaceuticalsPharmaceuticals & Biotechnology₹45.31 Cr | 10.58% | ₹45.31 Cr | 1.49 L |
| 2 | Zydus LifesciencesPharmaceuticals & Biotechnology₹39.82 Cr | 9.30% | ₹39.82 Cr | 3.43 L |
| 3 | PfizerPharmaceuticals & Biotechnology₹37.81 Cr | 8.83% | ₹37.81 Cr | 80.7K |
| 4 | Alivus Life SciencesPharmaceuticals & Biotechnology₹34.62 Cr | 8.08% | ₹34.62 Cr | 2.46 L |
| 5 | Concord BiotechPharmaceuticals & Biotechnology₹30.13 Cr | 7.03% | ₹30.13 Cr | 2.08 L |
| 6 | SMS PharmaceuticalsPharmaceuticals & Biotechnology₹28.73 Cr | 6.71% | ₹28.73 Cr | 7.73 L |
| 7 | IPCA LaboratoriesPharmaceuticals & Biotechnology₹26.63 Cr | 6.22% | ₹26.63 Cr | 1.35 L |
| 8 | Zydus WellnessFood Products₹24.18 Cr | 5.64% | ₹24.18 Cr | 4.56 L |
| 9 | Aurobindo PharmaPharmaceuticals & Biotechnology₹22.18 Cr | 5.18% | ₹22.18 Cr | 1.29 L |
| 10 | Strides Pharma SciencePharmaceuticals & Biotechnology₹10.48 Cr | 2.45% | ₹10.48 Cr | 1.02 L |
| 11 | Sumitomo Chemical IndiaFertilizers & Agrochemicals₹1.32 Cr | 0.31% | ₹1.32 Cr | 25.5K |
Equity holdings only, ISIN-verified, from Quant Mutual Fund's public monthly portfolio disclosure (Aug 2026). Not investment advice.
Weight = the position as a % of this fund's portfolio. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).